首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Rapid improvement of intracranial tuberculomas after addition of ofloxacin to first-line antituberculosis treatment.
【24h】

Rapid improvement of intracranial tuberculomas after addition of ofloxacin to first-line antituberculosis treatment.

机译:一线抗结核治疗中加入氧氟沙星后,颅内结核瘤迅速改善。

获取原文
获取原文并翻译 | 示例
           

摘要

Reported here is the case of a 9-year-old girl presenting with disseminated tuberculosis, the manifestations of which included mediastinal adenopathy, an osteolytic parietal lesion with a large associated scalp abscess, cerebral empyema, meningoencephalitis, and tuberculomas. No clear improvement was observed after 4 weeks of first-line antituberculosis treatment (10 mg/kg rifampin, 15 mg/kg isoniazid, 30 mg/kg ethambutol, 30 mg/kg pyrazinamide). The isolation of an isoniazid-resistant organism prompted institution of ofloxacin. Introduction of this drug was associated with dramatic improvement. Its good penetration into the central nervous system and its distribution into macrophages suggest that this drug may be of interest for the treatment of intracranial tuberculomas, particularly those due to isoniazid-resistant strains.
机译:此处报道的是一名9岁女孩,患有弥漫性结核病,其表现包括纵隔腺病,溶骨性顶叶病变伴有大量相关的头皮脓肿,脑积脓,脑膜脑炎和结核病。一线抗结核治疗(10 mg / kg利福平,15 mg / kg异烟肼,30 mg / kg乙胺丁醇,30 mg / kg吡嗪酰胺)治疗4周后,未观察到明显改善。异烟肼耐药生物的分离促使氧氟沙星的建立。引入这种药物可以显着改善病情。它对中枢神经系统的良好渗透性及其在巨噬细胞中的分布表明,该药物可能对治疗颅内结核瘤特别是异烟肼耐药菌株引起的结核病感兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号